These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19080227)

  • 1. [Risk factors of hypertension in IgA nephropathy].
    Li SH; Shi W; Wang WJ; Liang XL; Liu SX; Ye ZM; Zhang B; He CS; Xia YF; Ma JC
    Zhonghua Nei Ke Za Zhi; 2008 Nov; 47(11):893-6. PubMed ID: 19080227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors affecting the long-term outcome of IgA nephropathy].
    Yang NS; Wu QQ; Du Y; Zhang R; Li YJ; Ye RG; Yu XQ
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):597-600. PubMed ID: 16194415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
    Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
    Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis.
    Katafuchi R; Oh Y; Hori K; Komota T; Yanase T; Ikeda K; Omura T; Fujimi S
    Clin Nephrol; 1994 Apr; 41(4):191-8. PubMed ID: 8026110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of acute renal failure in IgA nephropathy.
    Wen YK; Chen ML
    Ren Fail; 2010 May; 32(4):428-33. PubMed ID: 20446779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A cumulative renal survival analysis of 495 cases of IgA nephropathy].
    Qin Y; Li XW; Li H; Duan L; Li Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):160-3. PubMed ID: 15171553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hypertension in patients with idiopathic IgA nephropathy.
    Chen Y; Tang Z; Yang G; Shen S; Yu Y; Zeng C; Chen H; Liu ZH; Li LS
    Kidney Blood Press Res; 2005; 28(4):251-8. PubMed ID: 16340218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
    Ibels LS; Györy AZ
    Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of vascular lesions in IgA nephropathy and their influencing factors, a study of 1,005 cases].
    Wu J; Chen XM; Shi SZ
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):289-93. PubMed ID: 12812644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X; Chen X; Liu S; Zhuang Y; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the predictors for superimposed preeclampsia in patients with IgA nephropathy].
    Suetsugu Y; Tokudome G; Sugano N; Yoshizawa T; Endo S; Hara Y; Takane K; Kuriyama S; Hosoya T
    Nihon Jinzo Gakkai Shi; 2011; 53(8):1139-49. PubMed ID: 22351992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP; van den Brand JA; Wetzels JF
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of IgA nephropathy in preschool children.
    Utsunomiya Y; Kado T; Koda T; Okada S; Hayashi A; Fukawaza A; Nakagawa T; Kanzaki S; Kasagi T
    Clin Nephrol; 2000 Dec; 54(6):443-8. PubMed ID: 11140804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.